What happened
GeneOne Life Science updated the terms of convertible bonds to raise US$3.41M, about 10.5% of its market value.
For context, this raise equals about 10.5% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$3.41M |
| vs. market value | 10.5% |
| Filed | 2026-03-25, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260325001358 → open original filing |
Source: DART. Information only, not investment advice.